av天堂官网在线观看-久久精品亚洲成在人线av-中文天堂最新版在线网-日韩精品极品视频在线观看

技術(shù)文章/ article

您的位置:首頁  -  技術(shù)文章  -  核苷逆轉(zhuǎn)錄酶 (nucleoside reverse transcriptase) 抑制劑——拉米夫定

核苷逆轉(zhuǎn)錄酶 (nucleoside reverse transcriptase) 抑制劑——拉米夫定

更新時(shí)間:2024-01-12      瀏覽次數(shù):3684

Lamivudine  


CAS號(hào)134678-17-4

英文名Lamivudine  

中文名拉米夫定

Synonyms: 拉米夫定; BCH-189

純度99+%

Formula  C8H11N3O3S          分子量  229.26

Appearance   White to off-white solid

生物活性Lamivudine (BCH-189) is an orally active nucleoside reverse transcriptase inhibitor (NRTI). Lamivudine can inhibit HIV reverse transcriptase 1/2 and also the reverse transcriptase of hepatitis B virus. Lamivudine salicylate can penetrate the CNS.

Lamivudine (BCH-189) 是一種具有口服活性的核苷逆轉(zhuǎn)錄酶 (nucleoside reverse transcriptase) 抑制劑 (NRTI)Lamivudine 可以抑制 HIV 逆轉(zhuǎn)錄酶 1 2 以及乙型肝炎病毒 (hepatitis B virus) 的逆轉(zhuǎn)錄酶。Lamivudine 可以透過血腦屏障。

研究領(lǐng)域

Reverse Transcriptase (逆轉(zhuǎn)錄酶)

Reverse transcriptases (RTs) are enzyme used to generate complementary DNA (cDNA) from an RNA template, a process termed reverse transcription. Reverse transcriptases (RTs) use an RNA template and a short primer complementary to the 3' end of the RNA to direct the synthesis of the first strand cDNA.

Nucleoside reverse transcriptase inhibitors (NRTIs) block reverse transcriptase (an HIV enzyme). Non-nucleoside reverse transcriptase inhibitors (NNRTIs) bind to and block HIV reverse transcriptase. HIV uses reverse transcriptase to convert its RNA into DNA (reverse transcription). Blocking reverse transcriptase and reverse transcription prevents HIV from replicating.

HIV (人類免疫缺陷病毒)

Human immunodeficiency virus

HIV (Human immunodeficiency virus) is a lentivirus (a subgroup of retrovirus) that causes the acquired immunodeficiency syndrome (AIDS), a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Infection with HIV occurs by the transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells. HIV infects vital cells in the human immune system such as helper T cells (specifically CD4+ T cells), macrophages, and dendritic cells. HIV infection leads to low levels of CD4+ T cells through a number of mechanisms, including apoptosis of uninfected bystander cells, direct viral killing of infected cells, and killing of infected CD4+ T cells by CD8 cytotoxic lymphocytes that recognize infected cells. When CD4+ T cell numbers decline below a critical level, cell-mediated immunity is lost, and the body becomes progressively more susceptible to opportunistic infections.

Anti-infection (抗感染)

Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.

Antibiotics specifically treat infections caused by bacteria, most commonly used types of antibiotics are: Aminoglycosides, Penicillins, Fluoroquinolones, Cephalosporins, Macrolides, and Tetracyclines. New other approaches such as photodynamic therapy (PDT) and antibacterial peptides have been considered as alternatives to kill bacteria.

The high rates of morbidity and mortality caused by fungal infections are associated with the current limited antifungal arsenal and the high toxicity of the compounds. The most common antifungal targets include fungal RNA synthesis and cell wall and membrane components, though new antifungal targets are being investigated.

Viral infections occur when viruses enter cells in the body and begin reproducing, often causing illness. Viruses are classified as DNA viruses or RNA viruses, RNA viruses include retroviruses, such as HIV, are prone to mutate. The currently available antiviral drugs target 4 main groups of viruses: herpes, hepatitis, HIV and influenza viruses. Drug resistance in the clinical utility of antiviral drugs has raised an urgent need for developing new antiviral drugs.

Antiprotozoal drugs are medicines that treat infections caused by protozoa. Of which, malaria remains a major world health problem following the emergence and spread of Plasmodium falciparum that is resistant to the majority of antimalarial drugs. At present, antimalarial discovery approaches have been studied, such as the discovery of antimalarials from natural sources, chemical modifications of existing antimalarials, the development of hybrid compounds, testing of commercially available drugs that have been approved for human use for other diseases and molecular modelling using virtual screening technology and docking.

HBV (乙型肝炎病毒)

Hepatitis B virus

HBV (Hepatitis B virus), abbreviated HBV, is a species of the genus Orthohepadnavirus, which is likewise a part of the Hepadnaviridae family of viruses. HBV causes the disease hepatitis B. The hepatitis B virus is classified as the type species of the Orthohepadnavirus, which contains three other species: the Ground squirrel hepatitis virus, Woodchuck hepatitis virus, and theWoolly monkey hepatitis B virus. The genus is classified as part of the Hepadnaviridae family. HBV is divided into four major serotypes (adr, adw, ayr, ayw) based on antigenic epitopes present on its envelope proteins, and into eight genotypes (A–H) according to overall nucleotide sequence variation of the genome. The genotypes have a distinct geographical distribution and are used in tracing the evolution and transmission of the virus. Differences between genotypes affect the disease severity, course and likelihood of complications, and response to treatment and possibly vaccination.

參考文獻(xiàn)

[1]. Colledge D, et al. Synergistic inhibition of hepadnaviral replication by lamivudine in combination with penciclovir in vitro. Hepatology. 1997 Jul;26(1):216-25.

[2]. Olaniyan LW, et al. Lamivudine-Induced Liver Injury. Open Access Maced J Med Sci. 2015 Dec 15;3(4):545-50.  

[3]. Mdanda S, et al. Zidovudine and Lamivudine as Potential Agents to Combat HIV-Associated Neurocognitive Disorder. Assay Drug Dev Technol. 2019 Oct;17(7):322-329.


CONTACT

辦公地址:中國(上海)自由貿(mào)易試驗(yàn)區(qū)臨港新片區(qū)新楊公路1666號(hào)3幢315室 EMAIL:2885066715@qq.com
掃碼關(guān)注公眾號(hào)
版權(quán)所有©2025 凱立德生物醫(yī)藥技術(shù)(上海)有限公司 All Rights Reserved   備案號(hào):滬ICP備15046197號(hào)-1   sitemap.xml技術(shù)支持:化工儀器網(wǎng)   管理登陸

TEL:021-58180488

掃碼關(guān)注公眾號(hào)
国产午夜精品自拍视频| 女同精品女同系列在线观看| 国产一区二区欧美久久| 成人作爱视频免费播放| 五月婷婷六月丁香伊人妞| 小黄片在线观看免费观看| 肥熟40多岁的肥熟女| 羞羞的视频在线观看免费| 麻豆视频91免费观看| 亚洲无砖砖区免费视频| 精品人妻一区二区三区在线av| 成人性生交大片免费看r链接| 成人黄色污秽网站下载| 99久久婷婷国产亚洲终合精品| 精品少妇人妻免费久久蜜臀av| 日韩av在线精品观看| 亚洲精品毛片一区二区| 亚洲一区二区视频免费看| 亚洲精品久久麻豆蜜桃| 亚洲天堂av日韩精品| 四虎成人免费在线视频| 亚洲成人一区二区三区在线观看| 国产成人夜色在线视频观看| 91麻豆国产精品视频| 国产成人一区二区免费av| 九九99九九99九九精品在线观看| 国产三级精品三级在线专区2| 成人午夜视频在线观看高清| 国产精品久久白浆一区二区| 亚洲午夜精品视频免费| 久久中文字幕av不卡一区二区| 国产精品伦一区二区视频| 亚洲中文字幕人妻av| 狠狠爱婷婷网五月天久久| 在线播放亚洲国产一区二区三| 日韩中文字幕专区在线| 一起草草视频在线观看| 国内精日韩欧中文的话| 香蕉大黄色香蕉在线观看| 加勒比在线一区二区三区| 日韩精品免费一区二区中文字幕|